Chronic Obstructive Pulmonary Disease * 12: New Treatments for COPD

Overview

Journal Thorax

Date 2003 Aug 30

PMID 12947145

Citations 21

Authors

P J Barnes

Affiliations

Soon will be listed here.

Citing Articles

Network Pharmacology and Experimental Verification Reveal the Regulatory Mechanism of Chuanbeimu in Treating Chronic Obstructive Pulmonary Disease.

Xian M, Xu J, Zheng Y, Zhang L, Zhao J, Chen J Int J Chron Obstruct Pulmon Dis. 2024; 19:799-813.

PMID: 38529478 PMC: 10962663. DOI: 10.2147/COPD.S442191.

Bronchoalveolar Lavage Fluid from Chronic Obstructive Pulmonary Disease Patients Increases Neutrophil Chemotaxis Measured by a Microfluidic Platform.

Ren J, Chen W, Zhong Z, Wang N, Chen X, Yang H Micromachines (Basel). 2023; 14(9).

PMID: 37763903 PMC: 10537285. DOI: 10.3390/mi14091740.

cAMP-PDE signaling in COPD: Review of cellular, molecular and clinical features.

Hasani Nourian Y, Salimian J, Ahmadi A, Salehi Z, Karimi M, Emamvirdizadeh A Biochem Biophys Rep. 2023; 34:101438.

PMID: 36865738 PMC: 9971187. DOI: 10.1016/j.bbrep.2023.101438.

The association between leukocyte telomere length and chronic obstructive pulmonary disease is partially mediated by inflammation: a meta-analysis and population-based mediation study.

Wang T, Jia Z, Li S, Li Y, Yu T, Lu T BMC Pulm Med. 2022; 22(1):320.

PMID: 35987624 PMC: 9392327. DOI: 10.1186/s12890-022-02114-8.

The Ethic of Access: An AIDS Activist Won Public Access to Experimental Therapies, and This Must Now Extend to Psychedelics for Mental Illness.

Campbell M, Williams M Front Psychiatry. 2021; 12:680626.

PMID: 34290631 PMC: 8287122. DOI: 10.3389/fpsyt.2021.680626.

References

Littner M, Ilowite J, Tashkin D, Friedman M, Serby C, Menjoge S . Long-acting bronchodilation with once-daily dosing of tiotropium (Spiriva) in stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 161(4 Pt 1):1136-42. DOI: 10.1164/ajrccm.161.4.9903044. View

Holm K, Spencer C . Bupropion: a review of its use in the management of smoking cessation. Drugs. 2000; 59(4):1007-24. DOI: 10.2165/00003495-200059040-00019. View

Burge P, Calverley P, Jones P, Spencer S, ANDERSON J, Maslen T . Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ. 2000; 320(7245):1297-303. PMC: 27372. DOI: 10.1136/bmj.320.7245.1297. View

Rossi D, Zlotnik A . The biology of chemokines and their receptors. Annu Rev Immunol. 2000; 18:217-42. DOI: 10.1146/annurev.immunol.18.1.217. View

Markham A, Lamb H . Infliximab: a review of its use in the management of rheumatoid arthritis. Drugs. 2000; 59(6):1341-59. DOI: 10.2165/00003495-200059060-00010. View

Souness J, Aldous D, Sargent C . Immunosuppressive and anti-inflammatory effects of cyclic AMP phosphodiesterase (PDE) type 4 inhibitors. Immunopharmacology. 2000; 47(2-3):127-62. DOI: 10.1016/s0162-3109(00)00185-5. View

Lee J, Kumar S, Griswold D, Underwood D, Votta B, Adams J . Inhibition of p38 MAP kinase as a therapeutic strategy. Immunopharmacology. 2000; 47(2-3):185-201. DOI: 10.1016/s0162-3109(00)00206-x. View

Barnes P . Chronic obstructive pulmonary disease. N Engl J Med. 2000; 343(4):269-80. DOI: 10.1056/NEJM200007273430407. View

Lancaster T, Stead L, Silagy C, Sowden A . Effectiveness of interventions to help people stop smoking: findings from the Cochrane Library. BMJ. 2000; 321(7257):355-8. PMC: 1118332. DOI: 10.1136/bmj.321.7257.355. View

10.

Delhase M, Li N, Karin M . Kinase regulation in inflammatory response. Nature. 2000; 406(6794):367-8. DOI: 10.1038/35019154. View

11.

Yokomizo T, Kato K, Terawaki K, Izumi T, Shimizu T . A second leukotriene B(4) receptor, BLT2. A new therapeutic target in inflammation and immunological disorders. J Exp Med. 2000; 192(3):421-32. PMC: 2193217. DOI: 10.1084/jem.192.3.421. View

12.

Paredi P, Kharitonov S, LEAK D, Ward S, Cramer D, Barnes P . Exhaled ethane, a marker of lipid peroxidation, is elevated in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162(2 Pt 1):369-73. DOI: 10.1164/ajrccm.162.2.9909025. View

13.

Ichinose M, Sugiura H, Yamagata S, Koarai A, Shirato K . Increase in reactive nitrogen species production in chronic obstructive pulmonary disease airways. Am J Respir Crit Care Med. 2000; 162(2 Pt 1):701-6. DOI: 10.1164/ajrccm.162.2.9908132. View

14.

Montuschi P, Collins J, Ciabattoni G, Lazzeri N, Corradi M, Kharitonov S . Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 2000; 162(3 Pt 1):1175-7. DOI: 10.1164/ajrccm.162.3.2001063. View

15.

Punturieri A, Filippov S, Allen E, Caras I, Murray R, Reddy V . Regulation of elastinolytic cysteine proteinase activity in normal and cathepsin K-deficient human macrophages. J Exp Med. 2000; 192(6):789-99. PMC: 2193285. DOI: 10.1084/jem.192.6.789. View

16.

Meja K, Seldon P, Nasuhara Y, Ito K, Barnes P, Lindsay M . p38 MAP kinase and MKK-1 co-operate in the generation of GM-CSF from LPS-stimulated human monocytes by an NF-kappa B-independent mechanism. Br J Pharmacol. 2000; 131(6):1143-53. PMC: 1572440. DOI: 10.1038/sj.bjp.0703684. View

17.

Casaburi R, Briggs Jr D, Donohue J, Serby C, Menjoge S, Witek Jr T . The spirometric efficacy of once-daily dosing with tiotropium in stable COPD: a 13-week multicenter trial. The US Tiotropium Study Group. Chest. 2000; 118(5):1294-302. DOI: 10.1378/chest.118.5.1294. View

18.

Smith K . National burden of disease in India from indoor air pollution. Proc Natl Acad Sci U S A. 2000; 97(24):13286-93. PMC: 27217. DOI: 10.1073/pnas.97.24.13286. View

19.

Fedorak R, Gangl A, Elson C, Rutgeerts P, Schreiber S, Wild G . Recombinant human interleukin 10 in the treatment of patients with mild to moderately active Crohn's disease. The Interleukin 10 Inflammatory Bowel Disease Cooperative Study Group. Gastroenterology. 2000; 119(6):1473-82. DOI: 10.1053/gast.2000.20229. View

20.

Hogg J . Chronic obstructive pulmonary disease: an overview of pathology and pathogenesis. Novartis Found Symp. 2001; 234:4-19; discussion 19-26. DOI: 10.1002/0470868678.ch2. View